Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2009 1
2011 1
2013 1
2014 4
2015 7
2016 5
2017 8
2018 8
2019 12
2020 10
2021 5
2022 6
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
A walk through tau therapeutic strategies.
Jadhav S, Avila J, Schöll M, Kovacs GG, Kövari E, Skrabana R, Evans LD, Kontsekova E, Malawska B, de Silva R, Buee L, Zilka N. Jadhav S, et al. Acta Neuropathol Commun. 2019 Feb 15;7(1):22. doi: 10.1186/s40478-019-0664-z. Acta Neuropathol Commun. 2019. PMID: 30767766 Free PMC article. Review.
NMR Studies of Tau Protein in Tauopathies.
Kitoka K, Skrabana R, Gasparik N, Hritz J, Jaudzems K. Kitoka K, et al. Front Mol Biosci. 2021 Nov 11;8:761227. doi: 10.3389/fmolb.2021.761227. eCollection 2021. Front Mol Biosci. 2021. PMID: 34859051 Free PMC article. Review.
Tau-mediated synaptic damage in Alzheimer's disease.
Jadhav S, Cubinkova V, Zimova I, Brezovakova V, Madari A, Cigankova V, Zilka N. Jadhav S, et al. Transl Neurosci. 2015 Oct 23;6(1):214-226. doi: 10.1515/tnsci-2015-0023. eCollection 2015. Transl Neurosci. 2015. PMID: 28123806 Free PMC article. Review.
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial.
Cullen NC, Novak P, Tosun D, Kovacech B, Hanes J, Kontsekova E, Fresser M, Ropele S, Feldman HH, Schmidt R, Winblad B, Zilka N. Cullen NC, et al. EBioMedicine. 2024 Jan;99:104923. doi: 10.1016/j.ebiom.2023.104923. Epub 2023 Dec 14. EBioMedicine. 2024. PMID: 38101301 Free PMC article. Clinical Trial.
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.
Basheer N, Buee L, Brion JP, Smolek T, Muhammadi MK, Hritz J, Hromadka T, Dewachter I, Wegmann S, Landrieu I, Novak P, Mudher A, Zilka N. Basheer N, et al. Acta Neuropathol Commun. 2024 Apr 4;12(1):52. doi: 10.1186/s40478-024-01748-5. Acta Neuropathol Commun. 2024. PMID: 38576010 Free PMC article. Review.
Head trauma in sports and risk for dementia.
Winblad B, Ankarcrona M, Johansson G, Novak P, Peter Thelin E, Zetterberg H, Blennow K. Winblad B, et al. J Intern Med. 2019 Jun;285(6):591-593. doi: 10.1111/joim.12918. Epub 2019 May 15. J Intern Med. 2019. PMID: 31090251 Free article. No abstract available.
MIRRAGGE - Minimum Information Required for Reproducible AGGregation Experiments.
Martins PM, Navarro S, Silva A, Pinto MF, Sárkány Z, Figueiredo F, Pereira PJB, Pinheiro F, Bednarikova Z, Burdukiewicz M, Galzitskaya OV, Gazova Z, Gomes CM, Pastore A, Serpell LC, Skrabana R, Smirnovas V, Ziaunys M, Otzen DE, Ventura S, Macedo-Ribeiro S. Martins PM, et al. Front Mol Neurosci. 2020 Nov 27;13:582488. doi: 10.3389/fnmol.2020.582488. eCollection 2020. Front Mol Neurosci. 2020. PMID: 33328883 Free PMC article. Review.
65 results